Position in BMY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$36,603,220
-$36,067,549 QoQ
Shares Held
635,252
-47.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#2
of 218 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 99.24974655727176.ToString("F0")%
Shared 0.ToString("F0")%
None 0.7502534427282401.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KAMES CAPITAL plc holds $1,010,877,249 across 9 Drug Manufacturers - General names. BMY ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,905,111 | $361,247,147 | |
| 2 | ABBV |
AbbVie Inc.
|
680,730 | $171,298,897 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,169,722 | $150,309,277 | |
| 4 | JNJ |
Johnson & Johnson
|
443,703 | $112,687,250 | |
| 5 | LLY |
ELI LILLY & Co
|
81,026 | $97,185,023 | |
| 6 | BIIB |
Biogen Inc.
|
241,101 | $52,092,282 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
635,252 | $36,603,220 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
192,146 | $24,275,725 |
All Filings in BMY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,603,220 | 635,252 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $72,670,769 | 1,198,199 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $32,940,025 | 610,679 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $9,134,824 | 202,546 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $9,375,854 | 202,546 | Shares | Sole | 2026-04-10 | |
| 2025-03-31 | $13,930,359 | 228,404 | Shares | Sole | 2026-04-10 | |
| 2024-12-31 | $12,740,988 | 225,265 | Shares | Sole | 2026-04-10 | |
| 2024-09-30 | $13,186,973 | 254,870 | Shares | Sole | 2026-04-10 | |
| 2024-06-30 | $12,914,833 | 310,976 | Shares | Sole | 2026-04-10 | |
| 2024-03-31 | $16,864,228 | 310,976 | Shares | Sole | 2026-04-10 | |
| 2023-12-31 | $18,856,322 | 367,498 | Shares | Sole | 2026-04-10 | |
| 2023-06-30 | $28,355,238 | 443,397 | Shares | Sole | 2026-04-10 | |
| 2023-03-31 | $76,155,610 | 1,098,768 | Shares | Sole | 2025-09-02 | |
| 2022-12-31 | $80,015,595 | 1,112,100 | Shares | Sole | 2023-10-19 | |
| 2022-09-30 | $78,466,724 | 1,103,766 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $63,605,773 | 826,049 | Shares | Sole | 2022-07-12 | |
| 2020-06-30 | $3,160,441 | 53,749 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $2,995,969 | 53,749 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||